Loading...
XKRX
092040
Market cap13mUSD
Aug 28, Last price  
970.00KRW
Name

Amicogen Inc

Chart & performance

D1W1MN
XKRX:092040 chart
P/E
P/S
0.45
EPS
Div yield, %
Shrs. gr., 5y
5.99%
Rev. gr., 5y
-18.38%
Revenues
Net income
CFO
Dividend
Dec 28, 2016400 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Amicogen, Inc. is an industrial biotechnology firm established in 2000, with its headquarters located in Jinju-si, South Korea, conducting business both domestically and globally. The company engineers and supplies a diverse range of specialized enzymes, such as CX and SP, that serve critical functions across the pharmaceutical, food, chemical, and energy sectors. In addition to enzymes, Amicogen produces innovative bio-ingredients, including N-acetylglucosamine for enhancing skin moisture and joint well-being; pinitol/D-chiro-inositol; collagen peptides and tripeptides aimed at promoting skin and general health; chitoslim and chitosan oligosaccharides; various lactic acid bacteria; as well as fucoxanthin, curezyme, food enzymes, and bamboo salt. Furthermore, the company markets its own consumer lines, K-nutra for health-related products and KeyClean for disinfectants, and also provides protein purification resins.
IPO date
Sep 12, 2013
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

No data to show